Here, we consider the genes CXCL11, CCL2 and APOBEC3A, as they are connected with autoimmune diseases, including systemic lupus erythematosus39,40 and thus potential therapeutic targets in the management of patients with lupus and, likely, other interferonopathies39–43. Here, CXCL11 is linked to autoimmune disease.